Such inhibitors could potentially disrupt these unique MSI2-RNA aromatic amino acids mediated base stacking interactions or MSI-RNA interactions, thus leading to inhibition of MSI1/MSI2-mediated biological functions and compromising, among others, the viability of cancer cells that depend on MSI1/MSI2. Here, MSI2 is linked to cancer.